On 15 April 2014, the Russian Government approved the state program "Development of the Pharmaceutical and Medical Industries in 2013-2025". The stated goal of the program is to assist the development of innovative domestic pharmaceutical and medical manufacturing by strengthening R&D, technological and manufacturing potential of the Russian pharmaceutical and medical manufacturers, as well as horizontal measures targeting improved IT systems and human resource development.

The Program's four sub-programs cover, respectively, the manufacturing of medicines, the manufacturing of medical devices and items, development of IT infrastructure and human resources and the grandfathered pre-2013 sectoral development program.

The Program is coordinated by the Ministry of Industry and Trade, and has a budget allocation of 93 billion rubles (USD 2.6b at April 2014 exchange rate) spread over 8 years. Half of the total eight-year budget is reserved to the grandfathered sectoral program, around a third is allocated to pharmaceuticals production.

Government support is to be instrumentalized through direct subsidies to manufacturers of (a) pharmaceuticals and (b) medical items, covering the set-up of new productions, clinical trial expenses, purchase of equipment, substances, and government-sponsored R&D.